Get a sharper view of patients’ medications, care & benefits
Value-based care is bringing more incentives to work across organizations to manage patient health—but success requires real-time information at the patient and population levels. Otherwise, it’s almost impossible to track incentivized care activities and avoid those with low value.
The Surescripts Network Alliance® is bringing value-based care success within reach by supplying insights to keep people well between provider visits. With more visibility into patients’ care and benefits, teams can easily pinpoint opportunities to improve adherence, avoid unnecessary costs and close gaps in care.
medication histories for populations delivered in 20221
reduction in 90-day follow-up calls after implementing Medication History for Populations2
of care locations in the U.S. have clinical events identifiable with Surescripts3
Key products to help you meet value-based care goals
Clinical Direct Messaging
Coordinate medication management, send referral and consultation notes, address controlled substance abuse and aid collaborative practice agreements.
Medication History for Populations
Easily identify patients within value-based care populations who may need help with their medications and monitor their activity to help keep them healthy over time.
Real-Time Prescription Benefit
Improve adherence with patient-specific cost and coverage insights as well as alternatives that have lower out-of-pocket costs or align better with the patient’s benefit plan.
Record Locator & Exchange
Surface clinical records to help determine whether patients are receiving recommended care and gain visibility into care events outside of the provider network.
E-Prescribing for Controlled Substances (EPCS)
The Surescripts Platform
Powering the future of healthcare
Health intelligence sharing at scale requires powerful infrastructure. The Surescripts Platform supports every Surescripts product and every Network Alliance participant with industry-leading reliability, security and scalability.